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Objectives: Patients with vestibular schwannoma (VS) frequently suffer from disabling
vestibular symptoms. This prospective follow-up study evaluates vestibular and auditory
function and impairment of quality of life due to vertigo, dizziness, and imbalance in
patients with unilateralVS of different sizes before/after microsurgical or radiosurgical treat-
ment.Methods:Thirty-eight patientswith unilateralVSwere included.Twenty-two received
microsurgery, 16 CyberKnife radiosurgery. Two follow-ups took place after a median of
50 and 186.5 days. Patients received a standardized neuro-ophthalmological examination,
electronystagmographywith bithermal caloric testing, and pure-tone audiometry. Quality of
life was evaluated with the Dizziness Handicap Inventory (DHI). Patient data was grouped
and analyzed according to the size of the VS (group 1: <20mm vs group 2: ≥20mm).
Results: In group 1, the median loss of vestibular function was +10.5% as calculated by
Jongkees Formula (range −43 to +52; group 2: median +36%, range −56 to +90). The
median change of DHI scores was −9 in group 1 (range −68 to 30) and +2 in group 2
(−54;+20). Median loss of hearing was 4 dB (−42; 93) in group 1 and 12 dB in group 2
(5; 42). Conclusion: Loss of vestibular function in VS clearly correlates with tumor size.
However, loss of vestibular function was not strictly associated with a long-term deteri-
oration of quality of life. This may be due to central compensation of vestibular deﬁcits
in long-standing large tumors. Loss of hearing before treatment was signiﬁcantly inﬂu-
enced by the age of the patient but not by tumor size. At follow-up 1 and 2, hearing was
signiﬁcantly inﬂuenced by the size of the VS and the manner of treatment.
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INTRODUCTION
Vestibular schwannoma (VS) is a benign tumor arising from the
Schwann cells surrounding the vestibular nerve. With an annual
incidence of 9.4/1,000,000, it is one of the more common benign
intracranial tumors (Tos et al., 1992). VSs grow within the internal
auditory canal and may extend into the cerebellopontine angle.
Next to loss of hearing and tinnitus, dizziness, or unsteadiness of
gait are common symptoms.
Vestibular deﬁcits have been shown to severely affect quality of
life (Pérez et al., 2003; Kammerlind et al., 2005). However, most
patients with a chronic loss of vestibular function regain their
balance due to the process of central vestibular compensation.
Central vestibular compensation consists of multiple processes
of perceptual, vestibulo-ocular, and vestibulo-spinal readjustment
after unilateral and also bilateral vestibular loss. It has been shown
to be rapid and mostly complete for static conditions. For dynamic
conditions (i.e., associated with high-frequency head movements)
it is often incomplete (for review see Brandt, 2000).
Treatment for VS is traditionally surgical. Due to technical
improvements, the outcome has greatly improved since the ﬁrst
operation on a VS by Sir Charles Balance in 1894. However, the
intervention is associated with potential risks including hearing
loss, facial nerve palsy, brainstem/cerebellar injury, cerebrospinal
ﬂuid ﬁstula, hydrocephalus,meningitis as well as with general risks
associated with microsurgery and anesthesia (Tonn et al., 2000).
Since the ﬁrst reported case of a VS treated by radiosurgery, this
approach has become a viable alternative to the microsurgical
approach (Leksell, 1983; Delbrouck et al., 2003; Sughrue et al.,
2009). Radiosurgery involves the single session application of a
high single dose of radiation to a precisely controlled intracra-
nial location, aiming to inhibit further tumor growth by inducing
avascular necrosis (Mack et al., 2002; Hempel et al., 2006). Usually,
hospitalization is not required with this method. However, it is not
without risk, possible complications including injury of the facial
or cochlear nerve, vertigo, hydrocephalus, headaches, and tinnitus
(Mack et al., 2002; Delbrouck et al., 2003; Hayhurst et al., 2005).
Since the ﬁrst prospective follow-up of vestibular morbidity
after treatment for VS in 2006, multiple analyses of the func-
tional outcome in these patients have been published (Pollock
et al., 2006). However, only few studies were conducted in a
prospective way (Myrseth et al., 2009). Furthermore, although
vertigo, dizziness, and unsteadiness of gait are common symptoms
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of VS (reported incidence between 49 and 66%), these symptoms
were often only assessed in a qualitative or semi-quantitative way
(El-Kashlan et al., 1998; Lynn et al., 1999; Heerma et al., 2000;
Inoue et al., 2001; Humphriss et al., 2003).
We present a prospective pilot study on patients with VS of
different sizes before and after radio- or microsurgical treatment.
The inﬂuence of the tumor and the treatment on the function of
the cranial nerves V, VII, VIII is investigated. The main focus of
interest is on the investigation of the vestibular nerve function.We
assess morbidity due to dizziness and unsteadiness of gait in two
groups of patients – deﬁned according to tumor size – using exten-
sive vestibular testing and standardized testing for impairment of
quality of life due to vertigo/imbalance. By comparing two groups
of patients withVS who differ according to tumor size – and hence
level of vestibular loss of function – we aim to elucidate the role of
vestibular compensation on quality of life in unilateral vestibular
disease.
PATIENTS AND METHODS
PATIENTS
Thirty-eight patients (21 male, 17 female) with unilateral VS
were included (median age 49 years, range 28–76). Twenty-two
received microsurgery, 16 radiosurgery. Decision as to the treat-
mentmodality wasmade according to tumor size (largest diameter
>2.5 cm was an indication for microsurgery), patient preference,
and diagnostic issues (i.e., in those cases, in which the diagnosis of
VS was uncertain, microsurgery was preferred). Follow-ups took
place after amedian of 50 (33 patients) and 186.5 days (37 patients;
some patients received the second follow-up only).
ASSESSMENT OF TUMOR SIZE
For tumor volumetry, the dose planning software (MultiPlan™)
of the CK system is used. The tumor is outlined in every MRI slice
resulting in a tumor region of interest (ROI). Then,multiplated by
the slice thickness all ROIs are summed up to calculate the tumor
volume.
MICROSURGERY
Surgery was performed with resection of the tumor via a ret-
rosigmoidal craniectomy. During all phases of tumor dissection,
electrophysiological neuromonitoring was performed by EMG
for facial nerve function and BAEP for hearing function, pro-
vided there was preserved hearing preoperatively. After watertight
closure of the dura, the craniectomy was sealed with bone cement.
RADIOSURGERY
All radiosurgical treatments were performed in an outpatient
setting.TheCyberKnife is a frameless, image-guided robotic radio-
surgery system (Adler et al., 1997). The therapeutic radiation
is generated by a small linear accelerator (linac) mounted on
the robotic arm. A G3 and a G4 linac were used in this study.
The dose rate (6MeV Photon radiation) was 3Gy/min with the
G3, and 6Gy/min with the G4. Treatment planning was per-
formed with the Multiplan Software (Accuray Inc., Sunnyvale, CA,
USA). Radiosurgery with the CyberKnife applies a non-coplanar,
non-isocentric treatment plan, which allows the delivery of a
homogeneous dose distribution with a steep dose gradient. The
dose prescription for VS was 12.5 – 13Gy at the tumor margin
which corresponded to the 65–70% isodose.
NEURO-OPHTHALMOLOGICAL AND -OTOLOGICAL EXAMINATION
All patients underwent a full and standardized neuro-
ophthalmological and -otological examination with special
emphasis on spontaneous nystagmus with Frenzel’s goggles in
primary position, lateral and vertical gaze direction, gaze-evoked
nystagmus, horizontal head impulse test, and determination of the
subjective visual vertical (SVV).
CLINICAL ASSESSMENT
Patients were assessed as to the presence of vertigo/unsteadiness
of gait, facial paresis, and hyp- or paraesthesia on the side of the
face ipsilateral to the VS.
ELECTRONYSTAGMOGRAPHY
Bithermal caloric testing was performed in all patients. Water irri-
gation was performed for 30 s at 30˚C for the cool irrigation and
44˚C for the warm irrigation. The mean peak slow phase veloc-
ity (SPV) was determined with Igor Pro Wave Metric (version
3.13) software. Since there is a large intersubject variability of the
nystagmus induced by caloric irrigation and a small intraindivid-
ual variability of the response of the right and the left labyrinth
in healthy subjects, the Jongkees’ “vestibular paresis formula”:
(((R30˚+R44˚)− (L30˚+ L44˚))/(R30˚+R44˚+ L30˚+ L44˚))×
100, was used, where, for instance, R30˚ is the mean peak SPV
during caloric irrigation with 30˚C water (Jongkees et al., 1962).
Absolute values were used to quantify (in percent) the unilateral
weakness of the affected ear.
AUDIOMETRY
Patients received standard pure-tone audiometry. The mean audi-
tory loss was calculated from loss of hearing (dB) at 500, 1000, and
2000Hz.
ASSESSMENT OF QUALITY OF LIFE
Impairment of quality of life by dizziness was evaluated with the
Dizziness Handicap Inventory (DHI). The inventory consists of
25 questions pertaining to the impairment of quality of life by ver-
tigo/imbalance. The maximum score is 100, the minimum score 0
points (a high score indicating a greater impairment of quality of
life by dizziness).
STATISTICS
The Stata/IC 11.1 software (Stata Corp. 4905 Lakeway Dr., College
Station, TX 77845, USA) and Microsoft Excel was used for sta-
tistical analysis. Tumor size and vestibular function as measured
by Jongkee’s formula and DHI scores respectively were correlated
using Spearman’s correlation coefﬁcient. Comparisons between
the groups regarding tumor size, DHI scores, and vestibular func-
tion were evaluated using the t -test for independent samples.
Analysis of variance (ANOVA/MANCOVA) and regression analy-
sis was used to assess the inﬂuence of predictor variables (patient’s
sex and age, tumor side, tumor diameter, treatment method)
on outcome variables (function of cranial nerves V, VII, VIII,
especially the vestibular nerve function). Non-parametric statisti-
cal dependence between two variables was assessed by Spearman’s
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rank correlation test. Two-group-proportion tests were performed
to compare dichotomous variables before and after treatment. The
differences inmean valueswere calculatedwith t -tests.A threshold
of 0.05 was applied.
ETHICS
All methods used were approved by the local ethics committee.
RESULTS
Group 1 (VS< 20mm) comprised 21 patients, group 2
(VS≥ 20mm) 18 patients. Patients in either group did not dif-
fer regarding age and gender (group 1: median age 46 years, 12
male; group 2: median age 52 years, 9 male). Due to selection cri-
teria (i.e., smaller tumors were more often treated radiosurgically
than large ones), patients in group 1 more frequently received
CyberKnife treatment (14 patients), whereas in group 2, patients
were more often treated microsurgically (16 patients).
GROUP 1 (VS< 20MM)
Vestibular function
All patients received bithermal caloric testing at baseline, i.e.,
before treatment. Caloric testing was performed in 17 patients
at the ﬁrst and 19 patients at the second follow-up. At baseline,
patients in this group had a median reduction of vestibular func-
tion of 38% (relative to unaffected side according to Jongkee’s
formula; range 6–100%). The patients had a moderate deterio-
ration of vestibular function [52% (18; 100%) reduction at the
ﬁrst and 53% (9; 100%) at the second follow-up], resulting in a
complete vestibular paresis in four patients (Figure 1).
Neuro-ophthalmology ﬁndings
In one patient, spontaneous nystagmus in primary position was
detected on clinical examination before treatment. In this patient,
spontaneous nystagmus persisted on the ﬁrst follow-up and had
disappeared by the second follow-up. In one patient without
spontaneous nystagmus at baseline, spontaneous nystagmus was
detected after treatment. Gaze-evoked nystagmus was present in
ﬁve patients before treatment. In three of them, the nystagmus
persisted after treatment, in the other two it had disappeared on
the ﬁrst follow-up. One other patient displayed gaze-evoked nys-
tagmus after treatment. The head impulse test revealed a loss of
the horizontal vestibulo-ocular reﬂex (VOR) on the affected side
in 10 patients of this group before treatment. In an additional four
patients the head impulse test becamepathological after treatment.
Mean deviation of the SVV increased slightly from 1.3˚ at baseline
to 1.6˚ and 2.1˚ at the ﬁrst and second follow-up. However, this
increase was not signiﬁcant.
Auditory function
The median loss of hearing was 28 dB (12; 80) at baseline, 33 dB
(8; deafness) at follow-up 1 and 37 dB (10; deafness) at follow-up
2.1 patient was deaf after treatment (microsurgery).
Symptoms and other clinical ﬁndings
Eighteen patients reported dizziness or unsteadiness of gait before
radio-/microsurgery. In 17 of them, dizziness/unsteadiness was
continuously present. Ten patients suffered from vertigo attacks.
Post-treatment, 14 patients complained of dizziness/unsteadiness
of gait (in 13 of these, the symptoms had been present before the
intervention), 2 patients had vertigo attacks. One of the patients
had a transient facial paresis before treatment, none had a facial
paresis after treatment. One patient reported facial paresthesia
before and after treatment. In twopatients,preexisting facial pares-
thesia disappeared after treatment, in another two patients, facial
paresthesia ﬁrst appeared after treatment.
Quality of life
The median DHI score at baseline was 32 in this group (range 0–
68). At the ﬁrst follow-up the median score was 26, at the second
follow-up 19. In the two patients with complete vestibular paresis,
self estimation of quality of life by DHI deteriorated in two and
slightly improved in the other two cases. Median change of DHI
scores (baseline – last follow-up available) was −9 (−68; 30).
GROUP 2 (VS≥ 20MM)
Vestibular function
In this group,onepatient had a complete unilateral vestibular pare-
sis before and 11 patients after treatment. Patients in this group
deteriorated from a median vestibular reduction of function of
64%before treatment (range 0–100) to 76% (ﬁrst follow-up; range
60–100) and 100% (second follow-up; range 7–100; Figure 2).
Neuro-ophthalmology ﬁndings
Only one patient in group 2 had spontaneous nystagmus in pri-
mary position before and after treatment (this patient had suffered
a periprocedural cerebellar ischemia). None of the other patients
developed spontaneous nystagmus post-treatment. Gaze-evoked
nystagmus was present in eight patients before treatment. In ﬁve
of these patients, the nystagmus persisted afterward. The head
impulse test was pathological on the affected side in 11 patients
before, and in 14 patients after treatment. Mean deviation of the
SVV increased from 2.0˚ at baseline to 2.2˚ at the ﬁrst follow-up
and to 3.0˚ at the second follow-up.
Auditory function
The median loss of hearing was 46 dB (10; 75) at baseline, 54 dB
(15; deafness) at follow-up 1 and 59 dB (20; deafness) at follow-up
2. Eight patients were deaf after treatment (all microsurgery).
Symptoms and other clinical ﬁndings
Twelve patients reported dizziness or unsteadiness of gait at base-
line, with four patients suffering from vertigo attacks. After treat-
ment, 14 patients complained of dizziness/unsteadiness of gait,
with 2 patients suffering from vertigo attacks. One of the patients
had a facial paresis before and after treatment, another one had a
transient facial paresis before treatment. One patient developed a
persisting facial paresis after surgery. None of the patients reported
facial hyp- or paresthesia before treatment. In four patients, this
symptom appeared after microsurgery. One patient suffered a
periprocedural right hemispheric cerebellar ischemia.
Quality of life
The median DHI score at baseline was 20 in this group (range
0–54). At the ﬁrst follow-up the median score was 6, at the sec-
ond follow-up 22. Median change of DHI scores (baseline – last
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FIGURE 1 | Median vestibular function measured according to
Jongkee’s formula after caloric irrigation, auditory loss, and
impairment of quality of life according to the DHI score at baseline,
follow-up 1, and follow-up 2 forVS<20mm (median; interquartile
range). Despite a moderate deterioration of vestibular function, quality of
life improved.
follow-up available) was +2 in (range −54 to +20). In those
patients with measurable vestibular function at baseline who pro-
gressed to complete unilateral vestibular paresis, median DHI
change was +2 (−32; 20). Evaluation of DHI scores at baseline
or at the follow-ups revealed no correlation with tumor size in
either group. The surprisingly low median DHI at the ﬁrst follow-
up may be due to confounding by the fact that those patients with
severe symptoms were not available at the ﬁrst follow-up as they
were still in rehabilitative care.
GROUP 1 VS. GROUP 2
The different tumor sizes in the two groups are reﬂected in the
higher degree of loss of vestibular function in group 2 before and
after surgery (64, 76, and 100% at baseline, ﬁrst follow-up and
second follow-up vs 38, 52, and 53% in group 1). DHI scores,
reﬂecting the impairment of quality of life in the two groups, did
not differ signiﬁcantly at baseline and follow-up 2 (20, 6, and 22
at baseline, ﬁrst follow-up and second follow-up vs 32, 26, and 19
in group 1). The majority of patients in each group complained
about vertigo: 86%/67% in group 1 and 67%/78% in group 2
(before/after treatment). However, vertigo attacks were more fre-
quent in patients with small VS before treatment (48%/10% in
group 1 vs 22%/11% in group 2 pre-/post-treatment). Facial and
trigeminal dysfunction was encountered more frequently in group
2, reﬂecting the larger size of the VS and the higher rate of micro-
surgical interventions in this group. The degree of loss of hearing
before treatment was signiﬁcantly inﬂuenced by the age of the
patient (p< 0.001) but not by tumor size. At follow-up 1 and 2,
hearing was signiﬁcantly worse in those patients with a large VS.
Age was not a signiﬁcant determinant for loss of hearing on the
follow-up visits (p< 0.08).
MICRO- VS RADIOSURGERY
To complement comparison between patients grouped according
to the size of their tumor, we also compared patients according
to the method of treatment used. Follow-up intervals did not dif-
fer between patients treated with either technique [radiosurgery:
median 62.5 days at follow-up 1 (44; 117), 208 days at follow-up 2
(166; 383); microsurgery: median 56.5 days (30; 114) and 195 days
(117; 302)]. Tumor size differed signiﬁcantly [p< 0.00001; mean
10.13mm (radiosurgery) vs 23.64mm (microsurgery)]. Whereas
there was no signiﬁcant loss of hearing after radiosurgery, micro-
surgery did alter hearing signiﬁcantly (p< 0.001). Loss of vestibu-
lar function and impairment of quality of life (DHI) on follow-up
1 were more pronounced in the microsurgery group. This did
not apply to follow-up 2. The method of treatment did not sig-
niﬁcantly inﬂuence the evolution of vestibular function between
baseline and follow-up 2. Neither did the patients’ sex or the size
and side of the VS.
DISCUSSION
AIM OF THE STUDY AND MAJOR FINDINGS
The aim of this prospective study was to evaluate the effect of loss
of vestibular function on quality of life in patients with VS of dif-
ferent sizes treated with micro- and radiosurgery. Whereas most
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FIGURE 2 | Median vestibular function measured according to
Jongkee’s formula after caloric irrigation, auditory loss, and
impairment of quality of life according to the DHI score at baseline,
follow-up 1, and follow-up 2 forVS≥20mm (median; interquartile
range). Despite a marked deterioration of vestibular function, DHI scores
remained relatively stable.
previous studies relied on qualitative or semi-quantitative para-
meters to quantify dizziness, we documented vestibular function
using electronystagmography with bithermal caloric testing and
the head impulse test (Lynn et al., 1999; Darrouzet et al., 2004;
Hempel et al., 2006). We also looked for central oculomotor and
vestibular dysfunction by a standardized neuro-ophthalmological
examination, as well as loss of auditory function and other cranial
nerve disorders. Quality of life was assessed using the standardized
DHI.
The results of this study allow drawing the following conclu-
sions: loss of auditory function does not correlate with the size
of the VS but with the method of treatment used. In contrast,
the loss of vestibular function clearly correlates with the size of
the schwannoma. In both groups (VS< 20mm vs VS≥ 20mm),
micro- and radiosurgery cause a further decrease of vestibular
function. However, the degree of loss of vestibular function does
not correlate with the impairment of activities of daily living due
to vertigo.
VERTIGO AND QUALITY OF LIFE IN LARGE VS
Previous studies show that dizziness and unsteadiness of gait are
common symptoms in patients with VS (Parving et al., 1992;
Driscoll et al., 1998; Lynn et al., 1999; Inoue et al., 2001; Darrouzet
et al., 2004). In our study, 64% of patients in group 2 complained
of these symptoms before treatment. In this group, more than
50% of the patients suffered from complete vestibular paresis after
micro-/radiosurgery as assessed by caloric testing and clinically
by the head–thrust test. Nonetheless, DHI scores in this group
were lower than in group 1 pre-treatment and remain relatively
stable in the post-operative follow-up with a median progression
of +2.
A possible explanation for this effect is that due to the severe
loss of vestibular function pre-treatment, central vestibular com-
pensation has already occurred. The major neuronal change in the
vestibular nuclei during central vestibular compensation appears
to be the recovery of resting activity in the vestibular nuclei ipsi-
lateral to the loss of peripheral vestibular input. There is also
evidence from animal data that transcommissural synaptic input
to the vestibular nuclei from the contralateral labyrinth increases
in efﬁcacy (Smith and Darlington, 1991; Curthoys and Halmagyi,
1999). Furthermore, visual compensation may contribute to cen-
tral vestibular compensation to reduce balance deﬁcits (Pyykkö
et al., 1995).
VERTIGO AND QUALITY OF LIFE IN SMALL VS
As in group 2, most patients in group 1 reported subjective dizzi-
ness or unsteadiness of gait. Although the size of the VS and the
degree of loss of vestibular function before treatment were signif-
icantly lower than in group 2, DHI scores were slightly – although
not signiﬁcantly – higher at baseline in this group. Whereas DHI
scores in group 2 remain stable pre- and post-treatment, they drop
by almost 40% after treatment in group 1.
This may be due to two factors. First of all, steady growth of
the neuroma with constant change in the vestibular input of the
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affected side renders central vestibular compensation more difﬁ-
cult compared to a scenario with complete – or almost complete –
but stable unilateral loss of vestibular function. Previous reports
support the hypothesis that changes in vestibular function affect
the quality of life more severely than the absolute degree of loss
of function: a metaanalysis reports a higher incidence of vertigo
in patients treated with low-dose gamma-knife radiation rather
than a high-dose radiation (Sughrue et al., 2009). The authors
claim that this may be due to a more complete dysfunction
of the vestibular nerve in the high-dose group. Another study
reports a higher incidence of pre-treatment vertigo in patients
with small and medium-sized VSs as compared to large schwan-
nomas (>4 cm; Heerma et al., 2000). In a detailed description of
the sensorimotor postural rearrangement after unilateral vestibu-
lar deafferentation in patients with VS, Parietti-Winkler et al.
(2006) found a poorer postural performance of patients before
surgery compared to that found 3months post-operative. They
assume that this reﬂects an inappropriate central compensation of
the tonic imbalance of the descending vestibulo-spinal inﬂuences
during tumor growth.
Furthermore, small VSs encroaching on an otherwise intact
vestibular nerve are likely to cause vertigo attacks which provoke
particular discomfort in patients. In our study, almost 50% of
patients in group 1 suffered from vertigo attacks as compared to
only 22% in group 2, whereas there was little difference in the rate
of continuous unsteadiness/dizziness. The number of patients suf-
fering from these particularly disabling vertigo attacks dropped by
almost 40% after treatment. Hence, the improvement in quality of
life after radio-/microsurgery may be due to central compensation
in the setting of a stable vestibular function aswell as to a reduction
of vertigo attacks.
CONCLUSION
Whereas loss of vestibular function in VS tends to be more severe
in large tumors, tumor size does not predict loss of quality of
life as assessed by DHI. This may be explained by central com-
pensation of vestibular deﬁcits in long-standing large tumors.
Furthermore, vertigo attacks seem to be more disruptive of qual-
ity of life than permanent unsteadiness/dizziness. Hence, even
patients with small VS should be recommended for treatment if
they suffer from disabling vertigo attacks.
The treatment modality (radio- vs microsurgery) should be
chosen on the basis of individual patient characteristics. Impor-
tant determinants are tumor size, diagnostic certainty, and patient
preference. Furthermore, the results of our study suggest that
the method of treatment does not inﬂuence the long-term (i.e.,
follow-up 2) outcome concerning vestibular function and qual-
ity of life. However, deterioration of hearing is more pronounced
after micro- than after radiosurgery.
Shortcomings of this trial are the relatively small number of
patients included and the selection bias regarding the choice of
treatment modality. In order to further investigate hearing and
vestibular function after radio- and microsurgery in VS and to
evaluate whether maintenance of vestibular function proves to be
advantageous for quality of life in the long course, we suggest
further follow-ups after two and more years post-treatment in a
larger group of patients who are more homogenous concerning
tumor size.
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